Optimal design for multiresponse pharmacokinetic-pharmacodynamic models - Dealing with unbalanced designs

被引:16
|
作者
Ogungbenro, Kayode
Gueorguieva, Ivelina
Majid, Oneeb
Graham, Gordon
Aarons, Leon
机构
[1] Univ Manchester, Ctr Appl Pharmacokinet Res, Manchester M13 9PL, Lancs, England
[2] Lilly Res Ctr, Global PK PD, Windlesham GU20 6PH, Surrey, England
[3] Pfizer Ltd, Sandwich CT13 9NJ, Kent, England
[4] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PL, Lancs, England
关键词
pharmacokinetics; pharmacodynamics; D-optimality; optimal design; multiresponse; nonlinear; fixed effects; mixed effects;
D O I
10.1007/s10928-006-9048-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This paper addresses the problem of determining D-optimal designs for multiresponse pharmacokinetic-pharmacodynanfic (PKPD) experiments where data on each response variable can be collected at different times. Most previous multiresponse model optimal design applications have considered the case where all response variables are measured at the same time points. However in practice it may not be possible to have all responses measured at the same sampling times. We propose an optimal design method to take into account the unbalanced nature of the problem. The method developed was applied to a PKPD problem that involved describing the time course of drug plasma concentrations, heart rate and mean arterial blood pressure for both a fixed effects and mixed effects regression model. Additionally a simulation study was carried out in NONMEM for one such population optimal design problem.
引用
收藏
页码:313 / 331
页数:19
相关论文
共 50 条
  • [1] Optimal Design for Multiresponse Pharmacokinetic–Pharmacodynamic Models – Dealing with Unbalanced Designs
    Kayode Ogungbenro
    Ivelina Gueorguieva
    Oneeb Majid
    Gordon Graham
    Leon Aarons
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2007, 34 : 313 - 331
  • [2] Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments
    Dette, Holger
    Pepelyshev, Andrey
    Wong, Weng Kee
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2012, 39 (03) : 295 - 311
  • [3] Simultaneous population optimal design for pharmacokinetic-pharmacodynamic experiments
    Hooker, A
    Vicini, P
    [J]. AAPS JOURNAL, 2005, 7 (04): : E759 - E785
  • [4] Simultaneous population optimal design for pharmacokinetic-pharmacodynamic experiments
    Andrew Hooker
    Paolo Vicini
    [J]. The AAPS Journal, 7
  • [5] A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic models
    Gueorguieva, Luelina
    Ogungbenro, Kayode
    Graham, Gordon
    Glatt, Sophie
    Aarons, Leon
    [J]. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2007, 86 (01) : 51 - 61
  • [6] Simultaneous versus sequential optimal design for pharmacokinetic-pharmacodynamic models with FO and FOCE considerations
    J. M. McGree
    J. A. Eccleston
    S. B. Duffull
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2009, 36 : 101 - 123
  • [7] Simultaneous versus sequential optimal design for pharmacokinetic-pharmacodynamic models with FO and FOCE considerations
    McGree, J. M.
    Eccleston, J. A.
    Duffull, S. B.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2009, 36 (02) : 101 - 123
  • [8] Optimal designs for composed models in pharmacokinetic–pharmacodynamic experiments
    Holger Dette
    Andrey Pepelyshev
    Weng Kee Wong
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2012, 39 : 295 - 311
  • [9] Development of translational pharmacokinetic-pharmacodynamic models
    Mager, D. E.
    Jusko, W. J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (06) : 909 - 912
  • [10] Pharmacokinetic-pharmacodynamic models for inhaled anaesthetics
    Kreuer, S.
    Bruhn, J.
    Wilhelm, W.
    Bouillon, T.
    [J]. ANAESTHESIST, 2007, 56 (06): : 538 - 556